According to Reuters, the British government called on Thursday for drugmakers to build an additional six weeks of medicines stockpiles to cope with potential supply disruption in the event of a no-deal Brexit. The highly regulated drugs sector is one of the most vulnerable to Britain’s decision to leave the European Union because of uncertainty as to how medicines oversight will function.